General Information of Drug-Metabolizing Enzyme (DME ID: DME0111)
DME Name Ecto-5'-nucleotidase (NT5E), Homo sapiens DME Info
UniProt ID
5NTD_HUMAN
EC Number    EC: 3.1.3.5     (Click to Show/Hide the Complete EC Tree)
Hydrolases
Ester bond hydrolase
Phosphoric monoester hydrolase
EC: 3.1.3.5
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Significant hypermethylation
Interaction Name DNMT-NT5E interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 1.57E-23; delta-beta: 4.91E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the NT5E gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between DNMT and NT5E can significantly affect the drug-metabolizing process of Ecto-5'-nucleotidase.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B90 Colorectal cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Transcription-factor regulation
                            ARNT-interacting protein (HIF1A) Colorectal cancer Activation
Uniprot ID
HIF1A_HUMAN
Interaction Name HIF1A-NT5E interaction [1]
Studied Cell Lines T84 cell line
Ensembl ID
ENSG00000100644
Description ARNT-interacting protein (HIF1A) is reported to activate the transcription of NT5E gene, which leads to an increased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between HIF1A and NT5E can activate the drug-metabolizing process of Ecto-5'-nucleotidase.
               ICD-11: 2C25 Lung cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-30a-5p Lung cancer Suppression
miRBase ID
MIMAT0000087
Interaction Name hsa-miR-30a-5p--NT5E regulation [2]
Studied Cell Lines A549 and H226 cell lines
Description hsa-miR-30a-5p is reported to suppress NT5E mRNA translation by binding to the 3' untranslated region (3'UTR) of NT5E mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase.
               ICD-11: 2C60 Breast cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Histone modification
                            Histone deacetylases (HDACs) Breast cancer Repression
Uniprot ID
HDAC1_HUMAN
Interaction Name HDACs-NT5E interaction [3]
Studied Cell Lines Human breast cancer cell lines
Description Histone deacetylases (HDACs) are reported to deacetylate the NT5E gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between HDACs and NT5E can inhibit the drug-metabolizing process of Ecto-5'-nucleotidase.
References
1 Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002 Oct;110(7):993-1002.
2 CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer. 2017 Feb 3;16(1):34.
3 Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells. Breast Cancer Res Treat. 2011 Jan;125(1):55-63.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.